ELAB ▼ -1.6% - PMGC Holdings Inc.
$ELAB - NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development
05-NOV-2026 07:31 AM ET
Share this post
More filings for $ELAB
ELAB ▼ -1.3% - PMGC Holdings Inc.Oct 8, 2026ELAB ▲ +0.6% - PMGC Holdings Inc.Oct 1, 2026ELAB ▼ -7.9% - PMGC Holdings Inc.Sep 29, 2026ELAB ▲ +1.7% - PMGC Holdings Inc.Sep 18, 2026ELAB ▲ +5.8% - PMGC Holdings Inc.Sep 1, 2026
View full $ELAB filing history →💬 Comments
Loading comments…
Leave a comment